Both crises, the climate crisis and the COVID-19 pandemic need collective mitigation support. In the context of COVID-19, the support of mitigation strategies has found its way to the forefront of debates. Our aim was to contribute empirical evidence to this debate by investigating mitigation behaviors across both crises and discussing similarities and differences. To this end, we drew on the Norm Activation Model and the concept of Social Identity to understand individuals' support of mitigation strategies in the climate crisis and their support of governmental strategies to mitigate the spread of the virus. Data were gathered within a Germany-wide survey ( = 3092) carried out in June and July 2020. Three predictors significantly explained the support of mitigation strategies in both crises: (1) by the pandemic emerged as the strongest predictor for support of COVID-19 mitigation strategies, whereas (2) with others making efforts to mitigate the climate crisis was the strongest predictor for support of climate crisis mitigation strategies. (3) that together with others one can make a substantial contribution to mitigate the respective crisis predicted support of mitigation strategies in the COVID-19 pandemic and the climate crisis to similar proportions. The results point to the need for targeting the communication of mitigation strategies in a pandemic on raising awareness for the collective nature of the problem whereas strengthening efficacy expectations and feelings of belonging, e.g. through participation processes, could generally strengthen the support of mitigation strategies in both crises.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584834 | PMC |
http://dx.doi.org/10.1016/j.jenvp.2022.101898 | DOI Listing |
Mol Diagn Ther
January 2025
Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.
Obecabtagene autoleucel (AUCATZYL) is a CD19-directed genetically modified autologous T cell immunotherapy which is being developed by Autolus for the treatment of hematological cancers and systemic lupus erythematosus. In comparison with other chimeric antigen receptor T (CAR T) therapies, obecabtagene autoleucel has a fast off-rate binder for CD19. Obecabtagene autoleucel received approval following positive results from the FELIX phase I/II trial in adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL), and it is the first CAR T therapy that does not have mandatory Risk Evaluation Mitigation Strategy monitoring requirements.
View Article and Find Full Text PDFJ Autism Dev Disord
January 2025
Emory University School of Medicine, Atlanta, GA, USA.
The present evaluation aimed to begin development of a survey tool for measuring workplace stressors specific to behavioral health providers in clinical settings for autism and related developmental disabilities: the Burnout Assessment for Developmental Disability Settings (BADDS). BADDS development was guided by Patient-Reported Outcomes Measurement Information System (PROMIS; Cella et al., (Journal of Clinical Epidemiology, 63(11), 1179-1194, 2010) procedures.
View Article and Find Full Text PDFCell Mol Life Sci
January 2025
Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.
Air pollution is a global environmental health hazard associated with elevated cardiovascular morbidity and mortality. Emerging evidence suggests that exposure to various air pollutants, specifically particulate matter (PM), ultrafine particulate matter (UFPM), and diesel exhaust particles, may exacerbate myocardial ischemia-reperfusion (I/R) injury. PM exposure can directly impair cardiomyocyte survival under ischemic conditions by inducing inflammation, oxidative stress, apoptosis, and dysregulation of non-coding RNAs.
View Article and Find Full Text PDFNaunyn Schmiedebergs Arch Pharmacol
January 2025
School of Pharmacy, RK University, Kasturbadham, Rajkot, Gujarat, 360020, India.
Hypertension, a prevalent cardiovascular condition affecting a substantial portion of the global population, remains a formidable health challenge associated with a multitude of complications. This review article provides a comprehensive examination of hypertension, its various complications, and the emergence of a novel management technique that shows promising potential in transforming the therapeutic landscape. Over the years, conventional treatment approaches, encompassing lifestyle modifications, dietary interventions, and pharmacotherapy, have been the mainstay in managing hypertension.
View Article and Find Full Text PDFAnn Hematol
January 2025
Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School (MHH), Hannover, Germany.
The prefibrotic phase of primary myelofibrosis (pre-PMF) represents a distinct subentity within the spectrum of myeloproliferative neoplasms (MPNs), recognized by the World Health Organization (WHO) and the International Consensus Classification (ICC). Pre-PMF is characterized by unique morphological, clinical, and molecular features, distinguishing it from essential thrombocythemia (ET) and overt myelofibrosis (overt-PMF). The diagnostic process for pre-PMF relies on bone marrow histology, identification of molecular mutations and exclusion of other myeloid neoplasms.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!